Related Experiment Video
Updated: Jun 25, 2026
12:03
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Towards a durable RNAi gene therapy for HIV-AIDS
Ben Berkhout1, Olivier ter Brake
1Academic Medical Center of the University of Amsterdam, Center for Infection and Immunity Amsterdam (CINIMA), Department of Medical Microbiology, Laboratory of Experimental Virology, Amsterdam, The Netherlands. b.berkhout@amc.uva.nl
Expert Opinion on Biological Therapy
|February 25, 2009
Summary
RNA interference (RNAi) offers a powerful antiviral strategy, particularly for targeting viruses like HIV-1. Early clinical trials show promising results for RNAi gene therapy, indicating a bright future for this therapeutic approach.
Area of Science:
- Molecular Biology
- Virology
- Gene Therapy
Background:
- RNA interference (RNAi) is recognized as a potent biological mechanism for combating viral infections.
- This mechanism offers a promising avenue for developing novel antiviral therapies.
Purpose of the Study:
- To review RNA interference (RNAi) strategies for targeting pathogenic human viruses.
- To specifically discuss RNAi gene therapy applications against Human Immunodeficiency Virus type 1 (HIV-1).
Main Methods:
- A comprehensive review of existing scientific literature was conducted.
- The focus was on studies detailing RNAi applications against viral pathogens.
Main Results:
- RNA interference (RNAi) demonstrates significant potential as an antiviral therapeutic strategy.
- The development of RNAi-based treatments is progressing, with initial clinical trials underway.
Conclusions:
- Antiviral RNAi therapeutics hold considerable promise for the future.
- Despite being a relatively recent discovery, RNAi is rapidly advancing towards clinical application, with ongoing trials for conditions like HIV-1.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...